Cite
HARVARD Citation
Kanesvaran, R. et al. (n.d.). LBA9Real-world assessment of clinical effectiveness and safety of pazopanib in patients with advanced or metastatic renal cell carcinoma (RCC) in Asia, North Africa and Middle East countries: A prospective, observational study (PARACHUTE). Annals of oncology. p. . [Online].